COMBINATION OF NIRAPARIB AND ANLOTINIB IN PATIENTS WITH RECURRENT OR METASTATIC ENDOMETRIAL CANCER: AN OPEN-LABEL, SINGLE-ARM, TWO-STAGE, PHASE II STUDY

被引：0

作者：

Ren, Yulan ^{[1
,2
]}

Lu, Jing ^{[2
,3
]}

Tian, Wenjuan ^{[1
,2
]}

Li, Haiming ^{[2
,3
]}

Wang, Huaying ^{[1
,2
]}

机构：

[1] Fudan Univ, Dept Gynecol Oncol, Shanghai Canc Ctr, Shanghai, Peoples R China

[2] Fudan Univ, Dept Oncol, Shanghai Med Coll, Shanghai Canc Ctr, Shanghai, Peoples R China

[3] Fudan Univ, Dept Radiol, Shanghai Canc Ctr, Shanghai, Peoples R China

来源：

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2022年 / 32卷

关键词：

D O I：

10.1136/ijgc-2022-igcs.239

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

EP148/#437

引用

页码：A107 / A107

页数：1

共 50 条

[41] Vemurafenib in metastatic melanoma patients with brain metastases: an open-label, single-arm, phase 2, multicentre study [J].

McArthur, G. A. ;

Maio, M. ;

Arance, A. ;

Nathan, P. ;

Blank, C. ;

Avril, M. -F. ;

Garbe, C. ;

Hauschild, A. ;

Schadendorf, D. ;

Hamid, O. ;

Fluck, M. ;

Thebeau, M. ;

Schachter, J. ;

Kefford, R. ;

Chamberlain, M. ;

Makrutzki, M. ;

Robson, S. ;

Gonzalez, R. ;

Margolin, K. .

ANNALS OF ONCOLOGY, 2017, 28 (03) :634-641

[42] Camrelizumab plus apatinib in patients with recurrent or metastatic nasopharyngeal carcinoma failing first-line therapy: An open-label, single-arm, phase II study [J].

Ding, X. ;

Zhang, W. ;

You, R. ;

Zou, X. ;

Wang, Z. ;

Ouyang, Y-F. ;

Liu, Y-L. ;

Peng, L. ;

You-Ping, L. ;

Duan, C-Y. ;

Yang, Q. ;

Lin, C. ;

Yulong, X. ;

Chen, S-Y. ;

Gu, C-M. ;

Huang, P. Y. ;

Hua, Y. ;

Chen, M. .

ANNALS OF ONCOLOGY, 2022, 33 (07) :S846-S846

[43] A phase II, open-label, single-arm trial of pembrolizumab for recurrent meningioma and solitary fibrous tumor [J].

Limon, Dror ;

Amiel, Alexandra ;

Haim, Shaked Even ;

Gordon, Noa ;

Tschernichovsky, Roi ;

Stemmer, Salomon ;

Gal, Omer ;

Laviv, Yosef ;

Kanner, Andrew ;

Siegal, Tali ;

Yust-Katz, Shlomit .

NEURO-ONCOLOGY ADVANCES, 2024, 6 (01)

[44] Regorafenib-Avelumab Combination in Patients with Microsatellite Stable Colorectal Cancer (REGOMUNE): A Single-arm, Open-label, Phase II Trial [J].

Cousin, Sophie ;

Cantarel, Coralie ;

Guegan, Jean-Philippe ;

Gomez-Roca, Carlos ;

Metges, Jean-Philippe ;

Adenis, Antoine ;

Pernot, Simon ;

Bellera, Carine ;

Kind, Michele ;

Auzanneau, Celine ;

Le Loarer, Francois ;

Soubeyran, Isabelle ;

Bessede, Alban ;

Italiano, Antoine .

CLINICAL CANCER RESEARCH, 2021, 27 (08) :2139-2147

[45] Toripalimab in combination with anlotinib in previously treated recurrent or metastatic nasopharyngeal carcinoma: The interim analysis of the single-arm, phase II TORAL study [J].

Cai, Q. ;

Zou, Q. ;

Zhang, Y. ;

Xia, Y. ;

Liu, P. ;

Su, N. ;

Wang, J. ;

Tian, X. .

ANNALS OF ONCOLOGY, 2023, 34 :S579-S579

[46] Intercalated combination of chemotherapy and erlotinib for stage IIIA non-small-cell lung cancer: a multicenter, open-label, single-arm, phase II study [J].

Chen, Zhiwei ;

Shen, Shengping ;

Shi, Wenbo ;

Jiang, Gening ;

Wang, Xin ;

Jian, Hong ;

Zhou, Zhen ;

Ding, Zhengping ;

Lu, Shun .

CANCER MANAGEMENT AND RESEARCH, 2019, 11 :6543-6552

[47] A single-arm, open-label, multi-cohort, multi-center phase II clinical study of anlotinib combined with penpulimab in the treatment of recurrent or metastatic gynecological cancer: ALTER-GO-020 [J].

Wang, Dengfeng ;

Zhang, Guonan ;

Xiang, Yang ;

Liu, Hong .

GYNECOLOGIC ONCOLOGY, 2023, 176 :S155-S155

[48] A phase II, multicenter, open-label, single-arm trial of famitinib in patients with advanced recurrent and/or metastatic nasopharyngeal carcinoma (NPC) after two previous treatment regimens [J].

Huang, Yan ;

Zhang, Li ;

Pan, Jian-ji ;

Hu, Guoqing ;

Gang, Wu ;

Xiong, Jian Ping ;

Hu, Chaosu ;

Lin, Lizhu ;

Yu, Hao ;

Jiang, Haoyuan .

JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)

[49] Open-label, multicenter, single-arm phase II DeCOG-study of ipilimumab in pretreated patients with different subtypes of metastatic melanoma [J].

Zimmer, Lisa ;

Eigentler, Thomas K. ;

Kiecker, Felix ;

Simon, Jan ;

Utikal, Jochen ;

Mohr, Peter ;

Berking, Carola ;

Kaempgen, Eckhart ;

Dippel, Edgar ;

Stadler, Rudolf ;

Hauschild, Axel ;

Fluck, Michael ;

Terheyden, Patrick ;

Rompel, Rainer ;

Loquai, Carmen ;

Assi, Zeinab ;

Garbe, Claus ;

Schadendorf, Dirk .

JOURNAL OF TRANSLATIONAL MEDICINE, 2015, 13

[50] Open-label, multicenter, single-arm phase II DeCOG-study of ipilimumab in pretreated patients with different subtypes of metastatic melanoma [J].

Lisa Zimmer ;

Thomas K. Eigentler ;

Felix Kiecker ;

Jan Simon ;

Jochen Utikal ;

Peter Mohr ;

Carola Berking ;

Eckhart Kämpgen ;

Edgar Dippel ;

Rudolf Stadler ;

Axel Hauschild ;

Michael Fluck ;

Patrick Terheyden ;

Rainer Rompel ;

Carmen Loquai ;

Zeinab Assi ;

Claus Garbe ;

Dirk Schadendorf .

Journal of Translational Medicine, 13

← 1 2 3 4 5 →